Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study
- PMID: 29186515
- PMCID: PMC6186013
- DOI: 10.1093/ije/dyx236
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study
Abstract
Background: Coffee consumption has been shown to be associated with various health outcomes in observational studies. However, evidence for its association with epithelial ovarian cancer (EOC) is inconsistent and it is unclear whether these associations are causal.
Methods: We used single nucleotide polymorphisms associated with (i) coffee and (ii) caffeine consumption to perform Mendelian randomization (MR) on EOC risk. We conducted a two-sample MR using genetic data on 44 062 individuals of European ancestry from the Ovarian Cancer Association Consortium (OCAC), and combined instrumental variable estimates using a Wald-type ratio estimator.
Results: For all EOC cases, the causal odds ratio (COR) for genetically predicted consumption of one additional cup of coffee per day was 0.92 [95% confidence interval (CI): 0.79, 1.06]. The COR was 0.90 (95% CI: 0.73, 1.10) for high-grade serous EOC. The COR for genetically predicted consumption of an additional 80 mg caffeine was 1.01 (95% CI: 0.92, 1.11) for all EOC cases and 0.90 (95% CI: 0.73, 1.10) for high-grade serous cases.
Conclusions: We found no evidence indicative of a strong association between EOC risk and genetically predicted coffee or caffeine levels. However, our estimates were not statistically inconsistent with earlier observational studies and we were unable to rule out small protective associations.
Figures



References
-
- Huber WW, Rossmanith W, Grusch M, Haslinger E, et al.Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 2008;46:1230–38. - PubMed
-
- Huber WW, Scharf G, Nagel G, Prustomersky S, Schulte-Hermann R, Kaina B. Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver - comparison with phase II xenobiotic metabolism. Mutat Res 2003;522:57–68. - PubMed
-
- Boettler U, Volz N, Teller N, et al.Induction of antioxidative Nrf2 gene transcription by coffee in humans: depending on genotype?. Mol Biol Rep 2012;39:7155–62. - PubMed
-
- Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 2014;53:25–38. - PubMed
-
- Lee JK, Kim K, Ahn Y, Yang M, Lee JE. Habitual coffee intake, genetic polymorphisms, and type 2 diabetes. Eur J Endocrinol 2015;172:595–601. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 CA017054/CA/NCI NIH HHS/United States
- R01 CA063682/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- N01 PC067010/PC/NCI NIH HHS/United States
- R01 CA122443/CA/NCI NIH HHS/United States
- K07 CA095666/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- C490/A6187/CRUK_/Cancer Research UK/United Kingdom
- P30 CA008748/CA/NCI NIH HHS/United States
- R01 CA083918/CA/NCI NIH HHS/United States
- P50 CA159981/CA/NCI NIH HHS/United States
- U01 CA069417/CA/NCI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- N01 PC035137/PC/NCI NIH HHS/United States
- R01 CA058860/CA/NCI NIH HHS/United States
- K07 CA143047/CA/NCI NIH HHS/United States
- P50 CA105009/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- R01 CA095023/CA/NCI NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- C490/A10124/CRUK_/Cancer Research UK/United Kingdom
- R01 CA136924/CA/NCI NIH HHS/United States
- R01 CA126841/CA/NCI NIH HHS/United States
- R01 CA054419/CA/NCI NIH HHS/United States
- R01 CA112523/CA/NCI NIH HHS/United States
- P30 CA072720/CA/NCI NIH HHS/United States
- R01 CA114343/CA/NCI NIH HHS/United States
- MOP-86727/CIHR/Canada
- R01 CA063678/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
- K07 CA080668/CA/NCI NIH HHS/United States
- K22 CA138563/CA/NCI NIH HHS/United States
- R03 CA115195/CA/NCI NIH HHS/United States
- C490/A10119/CRUK_/Cancer Research UK/United Kingdom
- UM1 CA176726/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA074850/CA/NCI NIH HHS/United States
- R01 CA058598/CA/NCI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- R01 CA087538/CA/NCI NIH HHS/United States
- R03 CA113148/CA/NCI NIH HHS/United States
- R01 CA149429/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical